C4 Therapeutics Stock Price on June 21, 2024

CCCC Stock  USD 4.31  0.07  1.60%   
Below is the normalized historical share price chart for C4 Therapeutics extending back to October 02, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of C4 Therapeutics stands at 4.31, as last reported on the 17th of December 2024, with the highest price reaching 4.53 and the lowest price hitting 4.24 during the day.
IPO Date
2nd of October 2020
200 Day MA
6.1334
50 Day MA
5.1824
Beta
3.056
 
Covid
If you're considering investing in CCCC Stock, it is important to understand the factors that can impact its price. C4 Therapeutics retains Efficiency (Sharpe Ratio) of -0.0967, which signifies that the company had a -0.0967% return per unit of price deviation over the last 3 months. C4 Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm C4 Therapeutics' Information Ratio of (0.11), market risk adjusted performance of (0.67), and Variance of 25.07 to double-check the risk estimate we provide.
  
At present, C4 Therapeutics' Stock Based Compensation To Revenue is projected to increase slightly based on the last few years of reporting. . At present, C4 Therapeutics' Price To Book Ratio is projected to increase based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 1.20, whereas Price To Sales Ratio is forecasted to decline to 12.84. CCCC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0967

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCCCC

Estimated Market Risk

 5.12
  actual daily
45
55% of assets are more volatile

Expected Return

 -0.49
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.1
  actual daily
0
Most of other assets perform better
Based on monthly moving average C4 Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of C4 Therapeutics by adding C4 Therapeutics to a well-diversified portfolio.
Price Book
1.2741
Enterprise Value Ebitda
(0.42)
Price Sales
9.0364
Shares Float
54.2 M
Wall Street Target Price
14.5

C4 Therapeutics Main Headline on 21st of June 2024

Filed transaction by C4 Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3

C4 Therapeutics Valuation on June 21, 2024

It is possible to determine the worth of C4 Therapeutics on a given historical date. On June 21, 2024 CCCC was worth 4.07 at the beginning of the trading date compared to the closed value of 4.24. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of C4 Therapeutics stock. Still, in general, we apply an absolute valuation method to find C4 Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of C4 Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against C4 Therapeutics' related companies.
 Open High Low Close Volume
  4.07    4.07    3.92    4.05    1,558,043  
06/21/2024
  4.07    4.36    4.06    4.24    8,876,101  
  4.25    4.72    4.25    4.71    1,696,922  
Backtest C4 Therapeutics  |  C4 Therapeutics History  |  C4 Therapeutics Valuation   PreviousNext  
Open Value
4.07
4.24
Closing Value
19.43
Upside

C4 Therapeutics Trading Date Momentum on June 21, 2024

On June 24 2024 C4 Therapeutics was traded for  4.71  at the closing time. The top price for the day was 4.72  and the lowest listed price was  4.25 . The trading volume for the day was 1.7 M. The trading history from June 24, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 11.08% . The overall trading delta against the current closing price is 9.91% .

C4 Therapeutics Fundamentals Correlations and Trends

By evaluating C4 Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among C4 Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CCCC financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About C4 Therapeutics Stock history

C4 Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CCCC is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in C4 Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing C4 Therapeutics stock prices may prove useful in developing a viable investing in C4 Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding49.6 M45 M
Net Loss-115.4 M-109.6 M

C4 Therapeutics Quarterly Net Working Capital

221.84 Million

C4 Therapeutics Stock Technical Analysis

C4 Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of C4 Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of C4 Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

C4 Therapeutics Period Price Range

Low
December 17, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

C4 Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

C4 Therapeutics December 17, 2024 Market Strength

Market strength indicators help investors to evaluate how C4 Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading C4 Therapeutics shares will generate the highest return on investment. By undertsting and applying C4 Therapeutics stock market strength indicators, traders can identify C4 Therapeutics entry and exit signals to maximize returns

C4 Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for C4 Therapeutics' price direction in advance. Along with the technical and fundamental analysis of CCCC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CCCC to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for CCCC Stock analysis

When running C4 Therapeutics' price analysis, check to measure C4 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy C4 Therapeutics is operating at the current time. Most of C4 Therapeutics' value examination focuses on studying past and present price action to predict the probability of C4 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move C4 Therapeutics' price. Additionally, you may evaluate how the addition of C4 Therapeutics to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments